enzymatic assay of ACET. We studied this possibility by performing the enzymatic assay on controls containing increasing concentrations of ACET in the presence of different therapeutic concentrations of NAC (Fig. 1A) . Evidently, NAC concentrations Ն100 mg/L cause a marked negative bias, reaching total suppression of the reaction in the presence of 10 g/L NAC. In contrast, similar concentrations of NAC have no effect on the ACET TDx immunoassay (Fig.  1B) . According to the TDx method manual, concentrations of up to 1000 mg/L NAC cause only a minimal bias of Ͻ1 mg/L ACET in this assay.
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Plasma concentrations of NAC after administration of the common initial dose of 150 mg/kg of body weight over a period of 15 min have been reported to range from 304 to 875 mg/L (5). NAC concentrations in this range, and certainly the higher concentrations of blood NAC reached after larger dosages during infusion, markedly impede ACET determination by the enzymatic assay (Fig. 1A) .
That the drug of choice for treating ACET intoxication produces a very large negative bias in a commonly used enzymatic-colorimetric assay of ACET is worth noting. On the basis of the present observation, we recommend that patients' blood should be sampled for ACET before the initiation of NAC treatment. Alternatively, enzyme-based colorimetric methods should be replaced by immunoassays or HPLC assays of ACET in which NAC causes no interference. A 55 years-old woman was admitted to the emergency room with suspected acetaminophen overdose. She had been found lying on the floor of her apartment in an altered level of consciousness, and a bottle of acetaminophen was discovered beside her. The patient had recently been hospitalized for a period of three months for depression. She had no history of diabetes. Capillary blood glucose as measured with the Glucometer Elite (Bayer) at the emergency room showed values of 8.4, 12.8, and 9.4 mmol/L (samples taken within 2.5 h of arrival). Serum analysis in the laboratory (Vitros 700 XR) gave glucose values Ͻ1.1 mmol/L for two different samples taken during that same time interval. Because of the discrepancy between the capillary glucose meter values and the serum glucose values measured by Vitros, the patient's serum was analyzed for glucose at another laboratory by Synchron CX-3 (0.11 mmol/ L), Synchron CX-5 (0.2 mmol/L), and Radiometer EML 105 (0.0 mmol/L). Her serum acetaminophen (Vitros 700 XR) was at the highly toxic concentration of 2904 mol/L. Despite appropriate treatment, the patient died the next night.
After ruling out a glucose meter defect as the source of the erroneously high glucose readings, acetaminophen interference was suspected. We therefore measured glucose on heparinized venous blood supplemented with different amounts of acetaminophen (50 L of aqueous solution per mL of blood). The blood samples were drawn from healthy volunteers who were not taking any medication. Some of these blood samples were made hypoglycemic by incubation at 37°C for 4 h. Confirmation of acetaminophen concentrations was done by measurement on a Vitros 700 XR. Simultaneous measurements of venous blood glucose was done on five different glucose meters according to the manufacturers' instructions. Glucose measurements were also done on whole venous blood (EML 105) and plasma (Vitros 700 XR, Synchron CX-3, and CX-5). Results of the glucose measurements on the Glucometer Elite (meter #1) and the Accuchek Advantage (meter #2) showed a positive interference that increased with the amount of acetaminophen added (Table 1) . Maximal deviations of 4.4 and 4.5 mmol/L were seen at the highest acetaminophen concentration. The Precision QID (meter #3) showed a negative interference (1.0 mmol/L at the highest acetaminophen concentration). No interferences were seen from the One Touch Profile (meter #4), the SureStep (meter #5), and from the laboratory glucose measuring instruments, including the EML 105. The Glucometer Elite and the Accu-chek Advantage were used to measure a low blood glucose value in the presence of the highest acetaminophen concentration tested above. A positive interference of the same amplitude was again observed (4.4 and 4.1 mmol/L, respectively), showing that the extent of the interference varied directly and in an absolute fashion with acetaminophen concentration, regardless of actual glucose concentration.
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It is worth noting that the three glucose meters that showed an interference measure glucose by electrochemical methods. The reflectance methodology used in the other two glucose meters did not show such an interference. The kit inserts provided by the manufacturers of Elite and Accu-chek Advantage do not state that such interference exists. The Precision QID information package does discuss a possible negative bias. The issue of interferences from reductive compounds such as acetaminophen on electrochemical glucose sensors has been addressed before (2) . Despite a 1992 report (3) on the Glucocard glucose meter (another brand name for the Bayer Elite), which identified a positive bias with acetaminophen, this issue has not been addressed in the recently published reports dealing with electrochemical glucose meters (4 -10) . Kit inserts should carry this information. The magnitude of the positive bias seen here with the Glucometer Elite and Accu-chek Advantage is such that the clinical management of patients suffering from acetaminophen intoxication and its complications (one being hypoglycemia) might be affected negatively. 
Louis-Jacques

Why "Urea Nitrogen" When Urea is Measured?
To the Editor: The paper by Morishita et al. (1) regarding the analysis of urea is confusing. In the text, the authors state that they are measuring urea nitrogen (UN), and it may seem so, because their calibrators were "physiological saline, with and without 17.86 mmol/L UN". However, the abstract states that analytical recovery of added urea was studied with patient sera containing 6.14 mmol/L urea. In contrast, the text describes patient sera with a UN concentration of 6.14 mmol/L. Because urea contains two nitrogens, these two sentences seem to be incompatible.
I think that if one is measuring urea, one should give the results in SI units (mmol/L) for the whole compound and not for the urea nitrogen. Otherwise, ambiguities arise in the interpretation of the results. Urea should be measured, and "urea nitrogen" should be abandoned as an analyte in clinical chemistry work. 
